Mark Aspinall-O’Dea
Charles River Laboratories (United Kingdom)(GB)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Advanced Proteomics Techniques and Applications, Monoclonal and Polyclonal Antibodies Research, Pancreatic and Hepatic Oncology Research, Acute Myeloid Leukemia Research
Most-Cited Works
- → In vitro reconstitution of the activated zeaxanthin state associated with energy dissipation in plants(2002)122 cited
- → The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors(2014)89 cited
- → A technically detailed and pragmatic protocol for quantitative serum proteomics using iTRAQ(2009)52 cited
- → hsa-mir183/EGR1–mediated regulation of E2F1 is required for CML stem/progenitor cell survival(2018)46 cited
- → Pancreatic Cancer: Proteomic Approaches to a Challenging Disease(2009)34 cited
- → A Specific PTPRC/CD45 Phosphorylation Event Governed by Stem Cell Chemokine CXCL12 Regulates Primitive Hematopoietic Cell Motility(2013)24 cited
- → Antibody-based detection of protein phosphorylation status to track the efficacy of novel therapies using nanogram protein quantities from stem cells and cell lines(2014)22 cited
- → ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing(2016)22 cited
- → The pancreatic cancer proteome – recent advances and future promise(2007)20 cited
- → Identification of Nuclear Protein Targets for Six Leukemogenic Tyrosine Kinases Governed by Post-Translational Regulation(2012)15 cited